Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis

European Journal of Cancer

Volumn 45, Issue 17, 2009, Pages 3008-3016

  Varadi, Verena ^a   Brendle, Annika ^a   Brandt, Andreas ^a   Johansson, Robert ^b   Enquist, Kerstin ^c   Henriksson, Roger ^b   Svenson, Ulrika ^c   Tavelin, Björn ^b   Roos, Göran ^c   Hemminki, Kari ^a,d   Lenner, Per ^b   Försti, Asta ^a,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Case control study; Single nucleotide polymorphism; Telomere

Indexed keywords

ACD PROTEIN; ESTROGEN RECEPTOR; POT1 PROTEIN; REGULATOR PROTEIN; TANKYRASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TNKS2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TELOMERE; TELOMERE-BINDING PROTEINS;

EID: 70350589292     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.012     Document Type: Article

References (26)

1. Jefford C.E., and Irminger-Finger I. Mechanisms of chromosome instability in cancers. Crit Rev Oncol Hematol 59 1 (2006) 1-14
2. Cheung A.L., and Deng W. Telomere dysfunction, genome instability and cancer. Front Biosci 13 (2008) 2075-2090
3. Bisoffi M., Heaphy C.M., and Griffith J.K. Telomeres: prognostic markers for solid tumors. Int J Cancer 119 10 (2006) 2255-2260
4. Barwell J., Pangon L., Georgiou A., et al. Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity?. Br J Cancer 97 12 (2007) 1696-1700
5. De Vivo I., Prescott J., Wong J.Y., et al. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 18 4 (2009) 1152-1156
6. Shen J., Terry M.B., Gurvich I., et al. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67 11 (2007) 5538-5544
7. Svenson U., Nordfjall K., Stegmayr B., et al. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 68 10 (2008) 3618-3623
8. Chang J.T., Chen Y.L., Yang H.T., Chen C.Y., and Cheng A.J. Differential regulation of telomerase activity by six telomerase subunits. Eur J Biochem 269 14 (2002) 3442-3450
9. Donigian J.R., and de Lange T. The role of the poly(ADP-ribose) polymerase tankyrase1 in telomere length control by the TRF1 component of the shelterin complex. J Biol Chem 282 31 (2007) 22662-22667
10. Kaminker P.G., Kim S.H., Taylor R.D., et al. TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J Biol Chem 276 38 (2001) 35891-35899
11. Xin H., Liu D., and Songyang Z. The telosome/shelterin complex and its functions. Genome Biol 9 9 (2008) 232
12. Salhab M., Jiang W.G., Newbold R.F., and Mokbel K. The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome. Breast Cancer Res Treat 109 1 (2008) 35-46
13. Kaaks R., Lundin E., Rinaldi S., et al. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Cause Control 13 4 (2002) 307-316
14. Wong K.K., Tsang Y.T., Shen J., et al. Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. Nucleic Acids Res 32 9 (2004) e69
15. Paez J.G., Lin M., Beroukhim R., et al. Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res 32 9 (2004) e71
16. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
17. Vaclavicek A., Hemminki K., Bartram C.R., et al. Association of prolactin and its receptor gene regions with familial breast cancer. J Clin Endocrinol Metab 91 4 (2006) 1513-1519
18. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 30 10 (2002) e47
19. Rakha E.A., Green A.R., Powe D.G., Roylance R., and Ellis I.O. Chromosome 16 tumor-suppressor genes in breast cancer. Gene Chromosome Cancer 45 6 (2006) 527-535
20. Savage S.A., Chanock S.J., Lissowska J., et al. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer 97 6 (2007) 832-836
21. Gelmini S., Poggesi M., Distante V., et al. Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. Cancer Lett 216 1 (2004) 81-87
22. Ahmed S., Thomas G., Ghoussaini M., et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009)
23. Easton D.F., and Eeles R.A. Genome-wide association studies in cancer. Hum Mol Genet 17 R2 (2008) R109-R115
24. Thomas G., Jacobs K.B., Kraft P., et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009)
25. Rafnar T., Sulem P., Stacey S.N., et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41 2 (2009) 221-227
26. Satyanarayana A., Manns M.P., and Rudolph K.L. Telomeres, telomerase and cancer: an endless search to target the ends. Cell Cycle 3 9 (2004) 1138-1150